Controlled delivery systems: From pharmaceuticals to cells and genes

Pharmaceutical Research

Volumn 28, Issue 6, 2011, Pages 1241-1258

  Balmayor, Elizabeth Rosado ^a   Azevedo, Helena Sepulveda ^a   Reis, Rui L ^a  

^a UNIVERSITY OF MINHO   (Portugal)

Author keywords

cell encapsulation; DDS routes of administration; gene therapy; growth factors; nanotechnology; regenerative medicine

Indexed keywords

ADRENALIN; ALGINIC ACID; BETA1A INTERFERON; BONE MORPHOGENETIC PROTEIN; CISPLATIN; COMPLEMENTARY DNA; DICLOFENAC; DILTIAZEM; ESTRADIOL; ETANERCEPT; ETHINYLESTRADIOL PLUS NORELGESTROMIN; FENTANYL; GLYCERYL TRINITRATE; GROWTH FACTOR; INFLUENZA VACCINE; METHYLPHENIDATE; NANOPARTICLE; NEUROTROPIC AGENT; NICOTINE; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; ONDANSETRON; OXYBUTYNIN; PARATHYROID HORMONE; PAROXETINE; POLYMER; SALBUTAMOL; SCOPOLAMINE; TESTOSTERONE; TRANSDERMAL SYSTEM; UNCLASSIFIED DRUG; UNINDEXED DRUG; VIRUS VECTOR;

ALLERGIC REACTION; ANEMIA; AUTO INJECTOR; BIODEGRADABILITY; BIOTRANSFORMATION; BLEEDING; CELL THERAPY; CHEMICAL BINDING; DNA MODIFICATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; ENCAPSULATION; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HYDROPHILICITY; IN VIVO STUDY; INFECTION; INHALATIONAL DRUG ADMINISTRATION; IONIC STRENGTH; MICROINJECTOR; MICROTECHNOLOGY; MULTIPLE SCLEROSIS; NANOFABRICATION; NANOTECHNOLOGY; NEEDLE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; OSTEOPOROSIS; PH; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; RHEUMATOID ARTHRITIS; SUSPENSION; TEMPERATURE; TISSUE ENGINEERING; TRANSDERMAL DRUG ADMINISTRATION; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; CHEMISTRY, PHARMACEUTICAL; DRUG ADMINISTRATION ROUTES; DRUG DELIVERY SYSTEMS; GENE TRANSFER TECHNIQUES; HUMANS; PHARMACEUTICAL PREPARATIONS; REGENERATIVE MEDICINE;

EID: 79959903835     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-011-0392-y     Document Type: Review

References (138)

1. AC Berkowitz DM Goddard 2009 Novel drug delivery systems: future directions J Neurosci Nurs 41 115 120 19361127
2. G Orive RM Hernández AR Gascón A Domínguez-Gil JL Pedraz 2003 Drug delivery in biotechnology: present and future Curr Opin Biotechnol 14 659 664 14662398 1:CAS:528:DC%2BD3sXps1Oqtbg%3D (Pubitemid 37518447)
3. Paolino D, Fresta M, Sinha P, Ferrari M. Drug Delivery Systems. In: Webster JG, editor. Encyclopedia of medical devices and instrumentation. New York: Wiley; 2006. p. 437-95.
4. ER Balmayor K Tuzlakoglu HS Azevedo RL Reis 2009 Preparation and characterization of starch-poly-caprolactone microparticles incorporating bioactive agents for drug delivery and tissue engineering applications Acta Biomater 5 1035 1045 19095509 1:CAS:528:DC%2BD1MXmt1aitLo%3D
5. PB Malafaya GA Silva RL Reis 2007 Natural-origin polymers as carriers and scaffolds for biomolecules and cell delivery in tissue engineering applications Adv Drug Deliv Rev 59 207 233 17482309 1:CAS:528:DC%2BD2sXmtlShur4%3D (Pubitemid 46879967)
6. E Wenk AJ Wandrey HP Merkle L Meinel 2008 Silk fibroin spheres as a platform for controlled drug delivery J Control Release 132 26 34 18761384 1:CAS:528:DC%2BD1cXhtlWhtrzN
7. W Ranade 1990 Drug delivery systems. Implants in drug delivery J Clin Pharmacol 30 871 889 2229447 1:STN:280:DyaK3M%2Fjs1Wisw%3D%3D
8. MJ Nitsch UV Banakar 1994 Implantable drug delivery J Biomater Appl 8 247 284 8176637 1:CAS:528:DyaK2cXisl2qsL0%3D
9. DP Pioletti O Gauthier VA Stadelmann B Bujoli J Guicheux PY Zambelli, et al. 2008 Orthopedic implant used as drug delivery system: clinical situation and state of the research Curr Drug Deliv 5 59 63 18220552 1:CAS:528: DC%2BD1cXktVegsQ%3D%3D (Pubitemid 351225635)
10. J Parvizi V Antoci NJ Hickok IM Shapiro 2007 Selfprotective smart orthopedic implants Expert Rev Med Devices 4 55 64 17187471 1:CAS:528: DC%2BD2sXhvFyltL8%3D (Pubitemid 46157682)
11. R Langer NA Peppas 2003 Advances in biomaterials, drug delivery, and bionanotechnology AIChE J 49 2990 3006 1:CAS:528:DC%2BD2cXhs1Wn (Pubitemid 38009884)
12. H Rosen T Abribat 2005 The rise and rise of drug delivery Nat Rev Drug Discov 4 381 385 15864267 1:CAS:528:DC%2BD2MXjs1OktLo%3D (Pubitemid 40704121)
13. KK Jain 1998 Strategies and technologies for drug delivery systems Trends Pharmacol Sci 19 155 157 1:CAS:528:DyaK1cXjsFyiurg%3D (Pubitemid 28255399)
14. G Orive AR Gascon RM Hernandez A Dominguez-Gil JL Pedraz 2004 Techniques: new approaches to the delivery of biopharmaceuticals Trends Pharmacol Sci 25 382 387 15219981 1:CAS:528:DC%2BD2cXlt1ansbw%3D (Pubitemid 38829492)
15. A Arora MR Prausnitz S Mitragotri 2008 Micro-scale devices for transdermal drug delivery Int J Pharm 364 227 236 18805472 1:CAS:528: DC%2BD1cXhtlOnurjO
16. MR Prausnitz R Langer 2008 Transdermal drug delivery Nat Biotechnol 26 1261 1268 18997767 1:CAS:528:DC%2BD1cXhtlCktrrF
17. MR Prausnitz S Mitragotri R Langer 2004 Current status and future potential of transdermal drug delivery Nat Rev Drug Discov 3 115 124 15040576 1:CAS:528:DC%2BD2cXhtlartbg%3D (Pubitemid 38239773)
18. S Scheindlin 2004 Transdermal drug delivery: past, present, future Mol Interv 4 308 312 15616157 (Pubitemid 40124375)
19. VD Vilivalam L Illum K Iqbal 2000 Starch capsules: an alternative system for oral drug delivery Pharm Sci Technolo Today 3 64 69 10664575 1:CAS:528:DC%2BD3cXhtFaks74%3D (Pubitemid 30101633)
20. S Majuru 2004 Advances in the oral delivery of heparin from solid dosage forms using emisphere's eligen® oral drug delivery technology Drug Deliv Technol 4 9 14
21. EA Hosny HI Al-Shora MM Elmazar 2002 Oral delivery of insulin from enteric-coated capsules containing sodium salicylate: effect on relative hypoglycemia of diabetic beagle dogs Int J Pharm 237 71 76 11955805 1:CAS:528:DC%2BD38XislyrsLc%3D (Pubitemid 34310480)
22. Rosenblatt JS, Berg RA. Collagen-based injectable drug delivery system and its use. 1998. US Patent Specification 5807581. United State
23. G Bernstein 2008 Delivery of insulin to the buccal mucosa utilizing the RapidMist™ system Expert Opin Drug Deliv 5 1047 1055 18754753 1:CAS:528:DC%2BD1cXhtVGktrnJ
24. P Rogueda 2005 Novel hydrofluoroalkane suspension formulations for respiratory drug delivery Expert Opin Drug Deliv 2 625 638 16296790 1:CAS:528:DC%2BD2MXmvFeltrk%3D (Pubitemid 41038676)
25. JZ Yang AL Young P-C Chiang A Thurston DK Pretzer 2008 Fluticasone and budesonide nanosuspensions for pulmonary delivery: Preparation, characterization, and pharmacokinetic studies J Pharm Sci 97 4869 4878 18351635 1:CAS:528:DC%2BD1cXhtlCgsLfN
26. JD Engstrom JM Tam MA Miller RO Williams KP Johnston 2008 Templated open flocs of nanorods for enhanced pulmonary delivery with pressurized metered dose inhalers Pharm Res 26 101 117 18758922
27. AC Williams BW Barry 2004 Penetration enhancers Adv Drug Deliv Rev 56 603 618 15019749 1:CAS:528:DC%2BD2cXhvFWqsbo%3D (Pubitemid 38326936)
28. Smith EW, Maibach HI. In: Smith EW, Maibach HI, editors. Percutaneous penetration enhancers. Boca Raton: CRC Press. Taylor & Francis Group; 2006. p. 4-14.
29. HK Vaddi PC Ho SY Chan 2002 Terpenes in propylene glycol as skin-penetration enhancers: Permeation and partition of haloperidol, fourier transform infrared spectroscopy, and differential scanning calorimetry J Pharm Sci 91 1639 1651 12115825 1:CAS:528:DC%2BD38XltVyitLo%3D (Pubitemid 34680226)
30. H Tang D Blankschtein R Langer 2002 Effects of low-frequency ultrasound on the transdermal permeation of mannitol: Comparative studies with in vivo and in vitro skin J Pharm Sci 91 1776 1794 12115805 1:CAS:528:DC%2BD38XlvV2ks7w%3D (Pubitemid 34810523)
31. DV McAllister MG Allen MR Prausnitz 2000 Microfabricated microneedles for gene and drug delivery Annu Rev Biomed Eng 2 289 313 11701514 1:CAS:528:DC%2BD3cXnsVaktbw%3D
32. DV McAllister PM Wang SP Davis JH Park PJ Canatella MG Allen, et al. 2003 Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: fabrication methods and transport studies Proc Natl Acad Sci USA 100 13755 13760 14623977 1:CAS:528:DC%2BD3sXpsFGisrw%3D (Pubitemid 37499139)
33. S Henry DV McAllister MG Allen MR Prausnitz 1998 Microfabricated microneedles: a novel approach to transdermal drug delivery J Pharm Sci 87 922 925 9687334 1:CAS:528:DyaK1cXkvVGktrw%3D (Pubitemid 28381247)
34. W Lin M Cormier A Samiee A Griffin B Johnson CL Teng, et al. 2001 Transdermal delivery of antisense oligonucleotides with microprojection patch (Macroflux) technology Pharm Res 18 1789 1793 11785702 1:CAS:528: DC%2BD38XhvVamsQ%3D%3D (Pubitemid 34020438)
35. W Martanto SP Davis NR Holiday J Wang HS Gill MR Prausnitz 2004 Transdermal delivery of insulin using microneedles in vivo Pharm Res 21 947 952 15212158 1:CAS:528:DC%2BD2cXktlykurw%3D (Pubitemid 38870143)
36. Cormier M, Daddona PE. Macroflux technology for transdermal delivery of therapeutic proteins and vaccines. In: Rathbone MJ, Hadgraft J, Roberts MS, editors. Modified-release drug delivery technology. New York: Marcel Dekker, Inc.; 2003. p. 589-98.
37. S Kaushik AH Hord DD Denson DV McAllister S Smitra MG Allen, et al. 2001 Lack of pain associated with microfabricated microneedles Anesth Analg 92 502 504 11159258 1:STN:280:DC%2BD3M7ktFCqtA%3D%3D (Pubitemid 32127644)
38. PE Laurent S Bonnet P Alchas P Regolini JA Mikszta R Pettis, et al. 2007 Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system Vaccine 25 8833 8842 18023942 1:CAS:528:DC%2BD2sXhsVWjt7vP (Pubitemid 350192056)
39. DP Wermeling SL Banks DA Hudson HS Gill J Gupta MR Prausnitz, et al. 2008 Microneedles permit transdermal delivery of a skin-impermeant medication to humans Proc Natl Acad Sci USA 105 2058 2063 18250310 1:CAS:528: DC%2BD1cXisVWmsbg%3D (Pubitemid 351439464)
40. CH Dean JB Alarcon AM Waterston K Draper R Early F Guirakhoo, et al. 2005 Cutaneous delivery of a live, attenuated chimeric flavivirus vaccine against Japanese encephalitis (ChimeriVax)-JE) in non-human primates Hum Vaccin 1 106 111 17012854 1:CAS:528:DC%2BD2MXhtFGrsbfJ
41. G Mutwiri TL Bowersock LA Babiuk 2005 Microparticles for oral delivery of vaccines Expert Opin Drug Deliv 2 791 806 16296779 1:CAS:528: DC%2BD2MXpvFOrtbw%3D (Pubitemid 41488843)
42. EC Lavelle DT O'Hagan 2006 Delivery systems and adjuvants for oral vaccines Expert Opin Drug Deliv 3 747 762 17076597 1:CAS:528:DC%2BD28XhtFOisLrL (Pubitemid 44781847)
43. A Maroni L Zema M Cerea ME Sangalli 2005 Oral pulsatile drug delivery systems Expert Opin Drug Deliv 2 855 871 16296783 1:CAS:528:DC%2BD2MXpvFOrtbg%3D (Pubitemid 41508713)
44. CT Rhodes SC Porter 1998 Coatings for controlled release drug delivery systems Drug Dev Ind Pharm 24 1139 1154 9876571 1:CAS:528:DyaK1cXnvFWqu7o%3D (Pubitemid 28546094)
45. I Lambkin C Pinilla 2002 Targeting approaches to oral drug delivery Expert Opin Biol Ther 2 67 73 11772341 1:CAS:528:DC%2BD38XnsVaktg%3D%3D (Pubitemid 34462462)
46. NA Peppas JR Robinson 1995 Bioadhesives for optimization of drug delivery J Drug Target 3 183 184 8705250 1:CAS:528:DyaK2MXpvVSrtrk%3D
47. EA Simone TD Dziubla VR Muzykantov 2008 Polymeric carriers: role of geometry in drug delivery Expert Opin Drug Deliv 5 1283 1300 19040392 1:CAS:528:DC%2BD1cXhsVegu7%2FF
48. RU Anderson D Mobley B Blank D Saltzstein J Susset JS Brown 1999 Once daily controlled versus immediate release oxybutynin chloride for urge urinary incontinence. OROS Oxybutynin Study Group J Urol 161 1809 1812 10332441 1:CAS:528:DyaK1MXjtlyrur8%3D (Pubitemid 29420737)
49. E Versi R Appell D Mobley W Patton D Saltzstein 2000 Dry mouth with conventional and controlled-release oxybutynin in urinary incontinence. The Ditropan XL Study Group Obstet Gynecol 95 718 721 10775736 1:CAS:528: DC%2BD3cXisFGntb4%3D (Pubitemid 30210058)
50. J Swanson S Gupta A Lam I Shoulson M Lerner N Modi, et al. 2003 Development of a new once-a-day formulation of methylphenidate for the treatment of attention-deficit/hyperactivity disorder: proof-of-concept and proof-of-product studies Arch Gen Psychiatry 60 204 211 12578439 1:CAS:528:DC%2BD3sXhsFyntbo%3D (Pubitemid 36173129)
51. U Conte L Maggi P Colombo A Lamanna 1993 Multilayered hydrophilic matrices as constant release devices (Geomatrix(Tm) Systems) J Control Release 26 39 47 1:CAS:528:DyaK3sXmtleqtrs%3D (Pubitemid 23204077)
52. U Conte L Maggi 1996 Modulation of the dissolution profiles from Geomatrix multi-layer matrix tablets containing drugs of different solubility Biomaterials 17 889 896 8718934 1:CAS:528:DyaK28XjtVKgt7g%3D (Pubitemid 26136568)
53. Y Ozsoy S Gungor E Cevher 2009 Nasal delivery of high molecular weight drugs Molecules 14 3754 3779 19783956 1:CAS:528:DC%2BD1MXht1egsbzL
54. SK Jain MK Chourasia AK Jain RK Jain AK Shrivastava 2004 Development and characterization of mucoadhesive microspheres bearing salbutamol for nasal delivery Drug Deliv 11 113 122 15200010 1:CAS:528:DC%2BD2cXjtFCmtrc%3D (Pubitemid 38437080)
55. S Gungor A Okyar S Erturk-Toker G Baktir Y Ozsoy 2010 Ondansetron-loaded chitosan microspheres for nasal antiemetic drug delivery: an alternative approach to oral and parenteral routes Drug Dev Ind Pharm 36 806 813 20136490 1:CAS:528:DC%2BC3cXmslChtbw%3D
56. T Loftsson ME Brewster 1996 Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization J Pharm Sci 85 1017 1025 8897265 1:CAS:528:DyaK28XlsFSrsr4%3D (Pubitemid 26338912)
57. FWHM Merkus JC Verhoef E Marttin SG Romeijn PHM van der Kuy WAJJ Hermens, et al. 1999 Cyclodextrins in nasal drug delivery Adv Drug Deliv Rev 36 41 57 10837708 1:CAS:528:DyaK1MXksFegtQ%3D%3D (Pubitemid 29074476)
58. RP Hayes D Muchmore J Schmitke 2007 Effect of inhaled insulin on patient-reported outcomes and treatment preference in patients with type 1 diabetes Curr Med Res Opin 23 435 442 17288697 1:CAS:528:DC%2BD2sXjsVOgs7Y%3D (Pubitemid 46333391)
59. B Otulana J Okikawa L Linn R Morishige J Thipphawong 2004 Safety and pharmacokinetics of inhaled morphine delivered using the AERx system in patients with moderate-to-severe asthma Int J Clin Pharmacol Ther Toxicol 42 456 462 1:CAS:528:DC%2BD2cXntVyhu7Y%3D (Pubitemid 39162778)
60. S Davison J Thipphawong J Blanchard K Liu R Morishige I Gonda, et al. 2005 Pharmacokinetics and acute safety of inhaled testosterone in postmenopausal women J Clin Pharmacol 45 177 184 15647410 1:CAS:528:DC%2BD2MXksFyht7w%3D (Pubitemid 40490441)
61. RG Jiang WS Pan CL Wang H Liu 2005 Use of recrystallized lactose as carrier for inhalation powder of interferon a2b Pharmazie 60 632 633 16124411 1:CAS:528:DC%2BD2MXosVaqtrY%3D (Pubitemid 41153432)
62. TR Hoare DS Kohane 2008 Hydrogels in drug delivery: progress and challenges Polymers 49 1993 2007 1:CAS:528:DC%2BD1cXktlahs7g%3D
63. PB Malafaya GA Silva ET Baran RL Reis 2002 Drug delivery therapies II.: strategies for delivering bone regenerating factors Curr Opin Solid State Mater Sci 6 297 312 1:CAS:528:DC%2BD38XpsFegtLo%3D (Pubitemid 36238388)
64. KY Lee DJ Mooney 2001 Hydrogels for tissue engineering Chem Rev 101 1869 1879 11710233 1:CAS:528:DC%2BD3MXjvFSqu7w%3D (Pubitemid 35377789)
65. Thompson I. Market trends: disposable mono-dose auto-injectors and pen-injectors. ONdrugDelivery. 2008;15-17.
66. Young M. The next generation of auto-injectors. ONdrugDelivery. 2010:4-7.
67. Dey-Pharma. EpiPen Autoinjector. www.dey.com ; www.epipen.com (accessed December 2010).
68. EMD Serono Inc. and Pfizer Inc. Rebif. www.rebif.com (accessed December 2010).
69. Amgen and Pfizer Inc. SureClick. www.enbrel.com (accessed December 2010).
70. BE Rabinow 2004 Nanosuspensions in drug delivery Nat Rev Drug Discov 3 785 796 15340388 1:CAS:528:DC%2BD2cXntFCns7o%3D (Pubitemid 39242830)
71. L Jia H Wong C Cerna SD Weitman 2002 Effect of nanonization on absorption of 301029: ex vivo and in vivo pharmacokinetic correlations determined by liquid chromatography/mass spectrometry Pharm Res 19 1091 1096 12240933 1:CAS:528:DC%2BD38XmtlGhurc%3D (Pubitemid 34984991)
72. GG Liversidge KC Cundy 1995 Particle-size reduction for improvement of oral bioavailability of hydrophobic drugs.1. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs Int J Pharm 125 91 97 1:CAS:528:DyaK2MXot12jsr0%3D
73. GG Liversidge P Conzentino 1995 Drug particle-size reduction for decreasing gastric irritancy and enhancing absorption of naproxen in rats Int J Pharm 125 309 313 1:CAS:528:DyaK2MXoslGmsbg%3D
74. WK Kraft B Steiger D Beussink JN Quiring N Fitzgerald HE Greenberg, et al. 2004 The pharmacokinetics of nebulized nanocrystal budesonide suspension in healthy volunteers J Clin Pharmacol 44 67 72 14681343 1:CAS:528: DC%2BD2cXls1Ojtg%3D%3D (Pubitemid 38005095)
75. Y Malam M Loizidou AM Seifalian 2009 Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer Trends Pharmacol Sci 30 592 599 19837467 1:CAS:528:DC%2BD1MXhtlCku7zI
76. R Duncan 2003 The dawning era of polymer therapeutics Nat Rev Drug Discov 2 347 360 12750738 1:CAS:528:DC%2BD3sXjslamtb0%3D (Pubitemid 37361705)
77. LY Qiu YH Bae 2006 Polymer architecture and drug delivery Pharm Res 23 1 30 16392022 1:CAS:528:DC%2BD28Xht1Clt7w%3D (Pubitemid 43214657)
78. KY Win SS Feng 2006 In vitro and in vivo studies on vitamin E TPGS-emulsified poly(D, L-lactic-co-glycolic acid) nanoparticles for paclitaxel formulation Biomaterials 27 2285 2291 16313953 1:CAS:528:DC%2BD2MXhtlWhsb7L (Pubitemid 41774539)
79. EC Gryparis M Hatziapostolou E Papadimitriou K Avgoustakis 2007 Anticancer activity of cisplatin-loaded PLGA-mPEG nanoparticles on LNCaP prostate cancer cells Eur J Pharm Biopharm 67 1 8 17303395 1:CAS:528: DC%2BD2sXntF2mtb0%3D (Pubitemid 46991325)
80. AK Bajpai SK Shukla S Bhanu S Kankane 2008 Responsive polymers in controlled drug delivery Prog Polym Sci 33 1088 1118 1:CAS:528: DC%2BD1cXhtlyqtbvE
81. G Frutos A Prior-Cabanillas R París I Quijada-Garrido 2010 A novel controlled drug delivery system based on pH-responsive hydrogels included in soft gelatin capsules Acta Biomater 6 4650 4656 20643229 1:CAS:528: DC%2BC3cXht12ktr7K
82. B-L Guo Q-Y Gao 2007 Preparation and properties of a pH/temperature- responsive carboxymethyl chitosan/poly(N-isopropylacrylamide)semi-IPN hydrogel for oral delivery of drugs Carbohydr Res 342 2416 2422 17669378 1:CAS:528:DC%2BD2sXhtVOlsb3M (Pubitemid 47525506)
83. R Suedee C Jantarat W Lindner H Viernstein S Songkro T Srichana 2010 Development of a pH-responsive drug delivery system for enantioselective- controlled delivery of racemic drugs J Control Release 142 122 131 19857533 1:CAS:528:DC%2BC3cXhs1Sgsb8%3D
84. K Zhang XYXY Wu 2004 Temperature and pH-responsive polymeric composite membranes for controlled delivery of proteins and peptides Biomaterials 25 5281 5291 15110479 1:CAS:528:DC%2BD2cXjtlyls7c%3D (Pubitemid 38521167)
85. T Niidome M Yamagata Y Okamoto Y Akiyama H Takahashi T Kawano, et al. 2006 PEG-modified gold nanorods with a stealth character for in vivo applications J Control Release 114 343 347 16876898 1:CAS:528: DC%2BD28Xpt1Omtbk%3D (Pubitemid 44310822)
86. H Li JD Carter TH LaBean 2009 Nanofabrication by DNA self-assembly Mater Today 12 24 32 1:CAS:528:DC%2BD1MXptlKgt7w%3D
87. GA Ozin K Hou BV Lotsch L Cademartiri DP Puzzo F Scotognella, et al. 2009 Nanofabrication by self-assembly Mater Today 12 12 23 1:CAS:528: DC%2BD1MXptlKgt74%3D
88. JD Byrne T Betancourt L Brannon-Peppas 2008 Active targeting schemes for nanoparticle systems in cancer therapeutics Adv Drug Deliv Rev 60 1615 1626 18840489 1:CAS:528:DC%2BD1cXhsVSjsL%2FP
89. P Shah 2006 Use of nanotechnologies for drug delivery MRS Bull 31 894 899 1:CAS:528:DC%2BD28XhtlarsLzO (Pubitemid 44826646)
90. LR Kaiser 1992 The future of multihospital systems Top Health Care Financ 18 32 45 1631884 1:STN:280:DyaK38zjs1artg%3D%3D
91. E Anitua M Sanchez G Orive I Andia 2008 Delivering growth factors for therapeutics Trends Pharmacol Sci 29 37 41 18037168 1:CAS:528: DC%2BD1cXis1ehsg%3D%3D
92. S Werner R Grose 2003 Regulation of wound healing by growth factors and cytokines Physiol Rev 83 835 870 12843410 1:CAS:528:DC%2BD3sXmtVGmsL0%3D (Pubitemid 36828927)
93. PC Bessa M Casal RL Reis 2008 Bone morphogenetic proteins in tissue engineering: the road from the laboratory to the clinic, part I (basic concepts) J Tissue Eng Regen Med 2 1 13 18293427 1:CAS:528:DC%2BD1MXlsleqsL0%3D
94. Wound Biotechnology, Department of Dermatology, School of Medicine, Boston University. Growth factors: their development and testing. http://www.bu.edu/woundbiotech/growthfactors/gfdevtest.html (accessed January 2011).
95. MH Alaoui-Ismaili D Falb 2009 Design of second generation therapeutic recombinant bone morphogenetic proteins Cytokine Growth Factor Rev 20 501 507 19910235 1:CAS:528:DC%2BD1MXhsV2msL%2FP
96. LA Fortier HO Mohammed G Lust AJ Nixon 2002 Insulin-like growth factor-I enhances cell-based repair of articular cartilage J Bone Joint Surg 84 276 288 1:STN:280:DC%2BD387ovFKlsw%3D%3D (Pubitemid 34257699)
97. EA Silva DJ Mooney 2007 Spatiotemporal control of vascular endothelial growth factor delivery from injectable hydrogels enhances angiogenesis J Thromb Haemost 5 590 598 17229044 1:CAS:528:DC%2BD2sXktFCisrs%3D (Pubitemid 46680694)
98. RR Chen EA Silva WW Yuen DJ Mooney 2007 Spatio-temporal VEGF and PDGF delivery patterns blood vessel formation and maturation Pharm Res 24 258 264 17191092 (Pubitemid 46072185)
99. L Meinel E Zoidis J Zapf P Hassa MO Hottiger JA Auer, et al. 2003 Localized insulin-like growth factor I delivery to enhance new bone formation Bone 33 660 672 14555272 1:CAS:528:DC%2BD3sXnvVersLw%3D (Pubitemid 37222393)
100. ZS Patel S Young Y Tabata JA Jansen ME Wong AG Mikos 2008 Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model Bone 43 931 940 18675385 1:CAS:528:DC%2BD1cXht1ejtLbJ
101. TA Holland Y Tabata AG Mikos 2003 In vitro release of transforming growth factor-beta 1 from gelatin microparticles encapsulated in biodegradable, injectable oligo(poly(ethylene glycol) fumarate) hydrogels J Control Release 91 299 313 12932709 1:CAS:528:DC%2BD3sXmsVSrsL0%3D (Pubitemid 36976762)
102. R Langer DA Tirrell 2004 Designing materials for biology and medicine Nature 428 487 492 15057821 1:CAS:528:DC%2BD2cXis1GksrY%3D (Pubitemid 38480528)
103. G Orive AR Gascon RM Hernandez M Igartua JL Pedraz 2003 Cell microencapsulation technology for biomedical purposes: novel insights and challenges Trends Pharmacol Sci 24 207 210 12767713 1:CAS:528: DC%2BD3sXktFGht7Y%3D (Pubitemid 36588862)
104. G Orive RM Hernandez AR Gascon M Igartua JL Pedraz 2002 Encapsulated cell technology: from research to market Trends Biotechnol 20 382 387 12175769 1:CAS:528:DC%2BD38XlvF2ktbw%3D (Pubitemid 34880173)
105. G Orive RM Hernandez AR Gascon R Calafiore TMS Chang P de Vos, et al. 2004 History, challenges and perspectives of cell microencapsulation Trends Biotechnol 22 87 92 14757043 1:CAS:528:DC%2BD2cXmvFyiug%3D%3D (Pubitemid 38130176)
106. A Murua A Portero G Orive RM Hernandez M de Castro JL Pedraz 2008 Cell microencapsulation technology: towards clinical application J Control Release 132 76 83 18789985 1:CAS:528:DC%2BD1cXhsVSqtLjE
107. P de Vos A Andersson SK Tam MM Faas JP Hallé 2006 Advances and barriers in mammalian cell encapsulation for treatment of diabetes Immunol Endocr Metab Agents Med Chem 6 139 153 (Pubitemid 43796735)
108. S Sakai I Hashimoto K Kawakami 2006 Development of alginate-agarose subsievesize capsules for subsequent modification with a polyelectrolyte complex membrane Biochem Eng J 30 76 81 1:CAS:528:DC%2BD28XktVGnsrY%3D
109. L Baruch M Machluf 2006 Alginate-chitosan complex coacervation for cell encapsulation: effect on mechanical properties and on long-term viability Biopolymers 82 570 579 16552738 1:CAS:528:DC%2BD28XnvFWrs7c%3D (Pubitemid 44204795)
110. TJ Wu HH Huang YM Hsu SR Lyu YJ Wang 2007 A novel method of encapsulating and cultivating adherent mammalian cells within collagen microcarriers Biotechnol Bioeng 98 578 585 17421039 1:CAS:528:DC%2BD2sXhtFansLbK (Pubitemid 47556126)
111. C Chung J Mesa GJ Miller MA Randolph TJ Gill JA Burdick 2006 Effects of auricular chondrocyte expansion on neocartilage formation in photocrosslinked hyaluronic acid networks Tissue Eng 12 2665 2673 16995800 1:CAS:528: DC%2BD28XpvVCrsrg%3D (Pubitemid 46141289)
112. LS Ferreira S Gerecht J Fuller HF Shieh G Vunjak-Novakovic R Langer 2007 Bioactive hydrogel scaffolds for controllable vascular differentiation of human embryonic stem cells Biomaterials 28 2706 2717 17346788 1:CAS:528: DC%2BD2sXjtVamur8%3D (Pubitemid 46420712)
113. SP Black I Constantinidis H Cui C Tucker-Burden CJ Weber SA Safley 2006 Immune responses to an encapsulated allogeneic islet beta-cell line in diabetic NOD mice Biochem Biophys Res Commun 340 236 243 16375863 1:CAS:528: DC%2BD2MXhtlCqtbbI (Pubitemid 41827671)
114. D Dufrane RM Goebbels A Saliez Y Guiot P Gianello 2006 Six-month survival of microencapsulated pig islets and alginate biocompatibility in primates: proof of concept Transplantation 81 1345 1353 16699465 (Pubitemid 43804557)
115. R Calafiore G Basta G Luca A Lemmi L Racanicchi F Mancuso, et al. 2006 Standard technical procedures for microencapsulation of human islets for graft into nonimmunosuppressed patients with type 1 diabetes mellitus Transplant Proc 38 1156 1157 16757293 1:CAS:528:DC%2BD28Xltl2htbw%3D (Pubitemid 43815904)
116. R Calafiore G Basta G Luca A Lemmi MP Montanucci G Calabrese, et al. 2006 Microencapsulated pancreatic islet allografts into nonimmunosuppressed patients with type 1 diabetes - First two cases Diab Care 29 137 138 (Pubitemid 44033446)
117. Y Hong HQ Song YH Gong ZW Mao CY Gao JC Shen 2007 Covalently crosslinked chitosan hydrogel: properties of in vitro degradation and chondrocyte encapsulation Acta Biomater 3 23 31 16956800 1:CAS:528:DC%2BD1cXhtVektLzE (Pubitemid 44804289)
118. B Inanc AE Elcin A Koc K Balos A Parlar YM Elcin 2007 Encapsulation and osteoinduction of human periodontal ligament fibroblasts in chitosan- hydroxyapatite microspheres J Biomed Mater Res A 82A 917 926 1:CAS:528:DC%2BD2sXpslCht7c%3D (Pubitemid 47312907)
119. S Sakai I Hashimoto K Kawakami 2008 Production of cell-enclosing hollow-core agarose microcapsules via jetting in water-immiscible liquid paraffin and formation of embryoid body-like spherical tissues from mouse ES cells enclosed within these microcapsules Biotechnol Bioeng 99 235 243 17705234 1:CAS:528:DC%2BD2sXhsVOrsLnJ
120. S Sakai I Hashimoto K Kawakami 2007 Agarose-gelatin conjugate for adherent cell-enclosing capsules Biotechnol Lett 29 731 735 17333466 1:CAS:528:DC%2BD2sXjvFansrs%3D (Pubitemid 46569226)
121. DF Emerich CG Thanos M Goddard SJM Skinner MS Geany WJ Bell, et al. 2006 Extensive neuroprotection by choroid plexus transplants in excitotoxin lesioned monkeys Neurobiol Dis 23 471 480 16777422 (Pubitemid 44097036)
122. D Kaigler PH Krebsbach Z Wang ER West K Horger DJ Mooney 2006 Transplanted endothelial cells enhance orthotopic bone regeneration J Dent Res 85 633 637 16798864 1:STN:280:DC%2BD28zotF2ksQ%3D%3D (Pubitemid 44085954)
123. TMS Chang 2005 Therapeutic applications of polymeric artificial cells Nat Rev Drug Discov 4 221 235 15738978 1:CAS:528:DC%2BD2MXhslSns78%3D
124. VP Torchilin 2006 Recent approaches to intracellular delivery of drugs and DNA and organelle targeting Annu Rev Biomed Eng 8 343 375 16834560 1:CAS:528:DC%2BD28Xpt1CltLk%3D (Pubitemid 44314821)
125. MB Chancellor N Yoshimura R Pruchnic J Huard 2001 Gene therapy strategies for urological dysfunction Trends Mol Med 7 301 306 11425638 1:CAS:528:DC%2BD3MXks1OktL8%3D (Pubitemid 32606569)
126. N Adachi D Pelinkovic CW Lee FH Fu J Huard 2001 Gene therapy and the future of cartilage repair Oper Tech Orthop 11 138 144 (Pubitemid 33795125)
127. VJ Wright HR Peng J Huard 2001 Muscle-based gene therapy and tissue engineering for the musculoskeletal system Drug Discov Today 6 728 733 11445464 1:CAS:528:DC%2BD3MXltVaksbg%3D (Pubitemid 32633920)
128. J Huard Y Li HR Peng FH Fu 2003 Gene therapy and tissue engineering for sports medicine J Gene Med 5 93 108 12539148 (Pubitemid 40309687)
129. N Kimelman G Pelled GA Helm J Huard EM Schwarz D Gazit 2007 Review: gene- and stem cell-based therapeutics for bone regeneration and repair Tissue Eng 13 1135 1150 17516852 1:CAS:528:DC%2BD2sXms1WhsLg%3D (Pubitemid 46986715)
130. A Usas J Huard 2007 Muscle-derived stem cells for tissue engineering and regenerative therapy Biomaterials 28 5401 5406 17915311 1:CAS:528: DC%2BD2sXht1WqtbnJ (Pubitemid 47599647)
131. T Sakai Y Ling TR Payne J Huard 2002 The use of ex vivo gene transfer based on muscle-derived stem cells for cardiovascular medicine Trends Cardiovasc Med 12 115 120 12007736 1:CAS:528:DC%2BD38Xjtl2mu7s%3D (Pubitemid 34462181)
132. L Meinel S Hofmann O Betz R Fajardo HP Merkle R Langer, et al. 2006 Osteogenesis by human mesenchymal stem cells cultured on silk biomaterials: comparison of adenovirus mediated gene transfer and protein delivery of BMP-2 Biomaterials 27 4993 5002 16765437 1:CAS:528:DC%2BD28XlvFakt7s%3D (Pubitemid 43866922)
133. H Hosseinkhani M Yamamoto Y Inatsugu Y Hiraoka S Inoue H Shimokawa, et al. 2006 Enhanced ectopic bone formation using a combination of plasmid DNA impregnation into 3-D scaffold and bioreactor perfusion culture Biomaterials 27 1387 1398 16139884 1:CAS:528:DC%2BD2MXht1Klu7fN (Pubitemid 41739564)
134. S Tirney CE Mattes N Yoshimura T Yokayama H Ozawa E Tzeng, et al. 2001 Nitric oxide synthase gene therapy for erectile dysfunction: comparison of plasmid, adenovirus, and adenovirus-transduced myoblast vectors Mol Urol 5 37 43 11689150 1:CAS:528:DC%2BD3MXivVOgs7c%3D (Pubitemid 32242556)
135. H Madry G Kaul M Cucchiarini U Stein D Zurakowski K Remberger, et al. 2005 Enhanced repair of articular cartilage defects in vivo by transplanted chondrocytes overexpressing insulin-like growth factor I (IGF-I) Gene Ther 12 1171 1179 15815701 1:CAS:528:DC%2BD2MXmtlCrs74%3D (Pubitemid 41136311)
136. AJ Nixon JL Haupt DD Frisbie SS Morisset CW McIlwraith PD Robbins, et al. 2005 Gene-mediated restoration of cartilage matrix by combination insulin-like growth factor-I/interleukin-1 receptor antagonist therapy Gene Ther 12 177 186 15578043 1:CAS:528:DC%2BD2MXptVWg (Pubitemid 40185921)
137. AF Steinert U Nöth RS Tuan 2008 Concepts in gene therapy for cartilage repair Inj Int J Care Injured 39 S97 S113
138. J Jo Y Tabata 2008 Non-viral gene transfection technologies for genetic engineering of stem cells Eur J Pharm Biopharm 68 90 104 17870447 1:CAS:528:DC%2BD2sXhsVSgtbvP (Pubitemid 350181423)